In July I successfully dosed the first Australian patient with tigilanol tiglate at The Kinghorn Cancer Centre, Sydney as part of QBiotics’ multi-centre Phase I/II


In July I successfully dosed the first Australian patient with tigilanol tiglate at The Kinghorn Cancer Centre, Sydney as part of QBiotics’ multi-centre Phase I/II


In a setting such as Sydney Hospital it is impossible not to reflect on the history of hospitals and surgery in Australia from the commencement


Head and neck cancer screening Surgeons and oncologists who work in Head and Neck Cancer Multidisciplinary Teams (MDTs) are qualified to screen patients for head
HPV doesn’t just cause cervical cancer High income countries like Australia are facing a human papillomavirus (HPV) related cancer epidemic. It is not cervical cancer